Overall, the anti-hyperglycemia potential demonstrated by 2-BI in our study could be a result of simultaneous action or synergism of A1 and A2A AR antagonism in key organs such as the liver, adipose tissue, muscle and pancreas in glucose and lipid homeostasis. This evidence concerns the gene AR and Hyperglycemia.